Mattia Rosso, MD
Clinical FellowAbout
Titles
Clinical Fellow
Appointments
Education & Training
- MHS-Med Ed
- Yale School of Medicine (2027)
- Clinical Fellow in Movement Disorders
- Yale New Haven Hospital (2026)
- Neurology Resident
- Medical University of South Carolina (2024)
- Chief Resident
- Medical University of South Carolina (2024)
- Postdoctoral Research Fellow
- Brigham and Women’s Hospital (2020)
- MD
- Università Vita-Salute San Raffaele (2017)
- Medical Student
- Università Vita-Salute San Raffaele (2017)
Board Certifications
Neurology
- Certification Organization
- ABPN
- Original Certification Date
- 2024
Research
Publications
2026
Dancing in Chaos: The Need for a Classification System for Chorea
Patino J, Mahajan A, Mendizabal A, Moore K, Zuchowski K, Rosso M, Espay A, Bang J, Testa C, Duker A, Walker R, Stimming E, Santini V. Dancing in Chaos: The Need for a Classification System for Chorea. Movement Disorders Clinical Practice 2026, 13: 1187-1191. PMID: 41527249, PMCID: PMC13172764, DOI: 10.1002/mdc3.70505.Peer-Reviewed Original Research
2025
The Influence of Videography in the Foundation and Future of Movement Disorders
Rosso M, Chu D, Barton B. The Influence of Videography in the Foundation and Future of Movement Disorders. Movement Disorders Clinical Practice 2025, 13: 359-368. PMID: 40857050, PMCID: PMC12911520, DOI: 10.1002/mdc3.70299.Peer-Reviewed Original ResearchThe Influence of Videography in the Foundation and Future of Movement Disorders
Rosso M, Chu D, Barton B. The Influence of Videography in the Foundation and Future of Movement Disorders. Mov Disord Clin Pract. 2025 Aug 26. doi: 10.1002/mdc3.70299. Epub ahead of print. PMID: 40857050.Peer-Reviewed Original ResearchA20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD
Lechner C, Saxena S, Lokhande H, Breu M, Eisenkölbl A, Karenfort M, Klein A, Leiz S, Preisel M, Rooney T, Rosso M, Schimmel M, Wendel E, Reindl M, Baumann M, Rostasy K, Chitnis T. A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGAD. Neurology Neuroimmunology & Neuroinflammation 2025, 12: e200452. PMID: 40825157, PMCID: PMC12363411, DOI: 10.1212/nxi.0000000000200452.Peer-Reviewed Original ResearchLaunching the Neurohumanities Network: An Online, Trainee-Led, Transdisciplinary Collaborative Effort to Foster Understanding of the Arts, Humanities, and Neurosciences (P5-5.004)
Doolittle J, Lewis C, Gheihman G, Rosso M, Palmer C, Stanley M. Launching the Neurohumanities Network: An Online, Trainee-Led, Transdisciplinary Collaborative Effort to Foster Understanding of the Arts, Humanities, and Neurosciences (P5-5.004). Neurology 2025, 104 DOI: 10.1212/wnl.0000000000211302.Peer-Reviewed Original Research
2024
Education Research: The Neurohumanities in Training
Rosso M, Greige T, Palmer C, Peng G, Ardakani R, Frolov A, George M, Carandang R, Gheihman G, Stanley M. Education Research: The Neurohumanities in Training. Neurology Education 2024, 3: e200178. PMID: 39748894, PMCID: PMC11694799, DOI: 10.1212/ne9.0000000000200178.Peer-Reviewed Original Research
2023
A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results
Lechner C, Saxena S, Lokhande H, Breu M, Eisenkölbl A, Karenfort M, Klein A, Leiz S, Preisel M, Rooney T, Rosso M, Schimmel M, Wendel E, Reindl M, Baumann M, Rostasy K, Chitnis T. A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results. Neuropediatrics 2023, 54: s1-s32. DOI: 10.1055/s-0043-1777141.Peer-Reviewed Original Research
2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
Lokhande H, Rosso M, Tauhid S, Chu R, Healy B, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz B, Kropshofer H, Granziera C, Leppert D, Kappos L, Kuhle J, Weiner H, Bakshi R, Chitnis T. Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS. Multiple Sclerosis Journal - Experimental Translational And Clinical 2022, 8: 20552173211069348. PMID: 35035990, PMCID: PMC8753083, DOI: 10.1177/20552173211069348.Peer-Reviewed Original Research
2021
Gaetano Perusini: The Forgotten Neuroscientist Behind “Alzheimer’s” Disease
Pellegrini F, Rosso M, Chu D. Gaetano Perusini: The Forgotten Neuroscientist Behind “Alzheimer’s” Disease. The Neuroscientist 2021, 29: 273-276. PMID: 34836480, DOI: 10.1177/10738584211059466.Peer-Reviewed Original ResearchTemporal trends of multiple sclerosis disease activity: Electronic health records indicators
Liang L, Kim N, Hou J, Cai T, Dahal K, Lin C, Finan S, Savovoa G, Rosso M, Polgar-Tucsanyi M, Weiner H, Chitnis T, Cai T, Xia Z. Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. Multiple Sclerosis And Related Disorders 2021, 57: 103333. PMID: 35158446, PMCID: PMC8849591, DOI: 10.1016/j.msard.2021.103333.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
20 York Street
New Haven, Connecticut 06510
United States